Sermorelin

Sermorelin is a synthetic peptide fragment of growth hormone-releasing hormone (GHRH 1–29) studied in research settings for its role in stimulating endogenous growth hormone secretion through pituitary signaling pathways. In simple terms, researchers use Sermorelin to better understand how the body naturally regulates growth hormone release and how short-acting GHRH analogs influence endocrine signaling in …

$45.00

Sermorelin is a synthetic peptide fragment of growth hormone-releasing hormone (GHRH 1–29) studied in research settings for its role in stimulating endogenous growth hormone secretion through pituitary signaling pathways. In simple terms, researchers use Sermorelin to better understand how the body naturally regulates growth hormone release and how short-acting GHRH analogs influence endocrine signaling in controlled laboratory models.

From a technical standpoint, Sermorelin is a 29-amino-acid peptide that corresponds to the biologically active region of endogenous GHRH. It functions as a selective agonist of the growth hormone-releasing hormone receptor (GHRH-R) located in the anterior pituitary gland. Activation of this receptor stimulates pulsatile growth hormone release, which in research models is associated with downstream IGF-1 signaling and broader somatotropic axis activity.

In laboratory research, Sermorelin is commonly evaluated within endocrine and metabolic signaling studies focusing on growth hormone secretion dynamics, pituitary responsiveness, and hypothalamic-pituitary regulation. Because it mirrors the natural signaling cascade more closely than direct growth hormone administration, it is frequently used as a model compound for studying physiological GH regulation patterns.

Sermorelin is intended strictly for laboratory research purposes only and is not approved for human consumption, medical use, or diagnostic applications.

Key Research Areas

  • Growth hormone-releasing hormone (GHRH) receptor activation
  • Pituitary growth hormone secretion studies
  • Somatotropic axis regulation research
  • Endocrine feedback loop modeling
  • IGF-1 signaling pathway studies

Chemical Information

  • Compound Name: Sermorelin (GHRH 1–29)
  • Type: Synthetic GHRH peptide fragment
  • Length: 29 amino acids
  • Mechanism: GHRH receptor agonist
  • Research Focus: Growth hormone axis signaling and regulation

Important Notice

This compound is sold strictly for laboratory research purposes only. It is not intended for human consumption, medical treatment, or diagnostic use. Proper handling and regulatory compliance are required by the purchaser.

Additional information